Vomiting News and Research

RSS
Vomiting is the process the body uses to eject some or all of the contents of the stomach through the mouth.
Faster, more sensitive test to detect ciguatera poisoning

Faster, more sensitive test to detect ciguatera poisoning

Positive results from Alkermes VIVITROL addiction study

Positive results from Alkermes VIVITROL addiction study

Three common scales are not accurate predictors of severe dehydration in children

Three common scales are not accurate predictors of severe dehydration in children

Amylin and Lilly terminate exenatide alliance, resolve litigation

Amylin and Lilly terminate exenatide alliance, resolve litigation

Salix enters definitive agreement to acquire Oceana Therapeutics

Salix enters definitive agreement to acquire Oceana Therapeutics

A.P. Pharma's third quarter net loss increases to $4.2 million

A.P. Pharma's third quarter net loss increases to $4.2 million

Vertex announces positive interim data from INCIVEK Phase 2 combination trial on HIV, HCV

Vertex announces positive interim data from INCIVEK Phase 2 combination trial on HIV, HCV

New data from Savient's KRYSTEXXA Phase III trial on refractory chronic gout

New data from Savient's KRYSTEXXA Phase III trial on refractory chronic gout

Longer looks: A doctor's dilemma on C-sections; apology for a death sparked a hospital's change

Longer looks: A doctor's dilemma on C-sections; apology for a death sparked a hospital's change

Final results from Vertex KALYDECO second of two Phase 3 studies on CF

Final results from Vertex KALYDECO second of two Phase 3 studies on CF

Takeda receives FDA approval for VELCADE sNDA to treat MM

Takeda receives FDA approval for VELCADE sNDA to treat MM

New computer-based tool enables early diagnosis of cancer

New computer-based tool enables early diagnosis of cancer

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

Avanir seeks EMA marketing authorization for NUEDEXTA to treat pseudobulbar affect

Avanir seeks EMA marketing authorization for NUEDEXTA to treat pseudobulbar affect

Pacira's third quarter total revenues decrease to $4.0 million

Pacira's third quarter total revenues decrease to $4.0 million

FDA approves Pacira's EXPAREL for postsurgical pain management

FDA approves Pacira's EXPAREL for postsurgical pain management

EC approves Lilly's ALIMTA as continuation maintenance therapy for NSCLC

EC approves Lilly's ALIMTA as continuation maintenance therapy for NSCLC

Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV

Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV

Vertex initiates INCIVEK combination Phase 3b study for hepatitis C

Vertex initiates INCIVEK combination Phase 3b study for hepatitis C

Janssen announces FDA label update approval for PREZISTA HIV tablets

Janssen announces FDA label update approval for PREZISTA HIV tablets

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.